George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 46,198 shares at $42.01 ($1.9M) on 2021-07-13, disclosed to the SEC on 2021-07-14.
Open-market sale of $1.9M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.04 | 100 | $4K | 0.2% |
| 2 | $42.01 | 5,068 | $213K | 11.0% |
| 3 | $42.01 | 5,068 | $213K | 11.0% |
| 4 | $42.01 | 17,981 | $755K | 38.9% |
| 5 | $42.01 | 17,981 | $755K | 38.9% |
| Total | $42.01 avg | 46,198 |
| $1.9M |
| 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |